PeptiCov

Developer of drug discovery intended to develop novel peptide molecules focusing on treatments for the SARS-Cov-2 virus.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2021
Last updated 2026-07-20
Total raised
$2.6M
Stage
Pre-Funding
Founded
2021
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

PeptiCov is a spin-off company of Pepticom, focused on discovering and developing effective treatments for SARS-CoV-2. It utilizes Pepticom's AI technology to design, discover, and develop novel peptide molecules for the treatment of the SARS-Cov-2 virus. The company aims to enable the world to live alongside the virus rather than remain in lockdowns and other drastic measures. PeptiCov is responsible for the further development of lab-validated peptide drug candidates and actively seeks partnerships with pharmaceutical companies.

Funding history · 1 round · $2.6M total

2021-03
Seed $2.6M CTech, March 2021

Q&A

What is PeptiCov's primary focus?
PeptiCov is focused on discovering and developing an effective treatment for SARS-CoV-2.
When was PeptiCov founded?
PeptiCov was founded in January 2021.
What is PeptiCov's current funding stage?
PeptiCov is currently in the Pre-Funding stage.
What is PeptiCov's relationship with PeptiCom?
PeptiCov is a spin-off company of PeptiCom, a biotechnology company that uses artificial intelligence to streamline peptide drug discovery.
What technology does PeptiCom utilize to develop drug candidates?
PeptiCom's AI technology streamlines and accelerates the discovery of advanced peptide-based drug candidates by searching an enormous set of possible solutions and filtering out suitable candidates with properties like solubility and permeability.
What is PeptiCov's role in the development of peptide drug candidates for SARS-CoV-2?
PeptiCov is responsible for the further development of peptide drug candidates designed by PeptiCom's AI software for SARS-CoV-2 and for seeking partnerships with pharmaceutical companies.
What is PeptiCov's primary sector classification?
PeptiCov's primary sector is Health Tech & Life Sciences.

Team · 2

Immanuel Lerner
Founder · Co-founder & CEO
Anwar Rayan
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

artificial-intelligencedrug-discoverytreatmentspharmaceuticalsanalysis-softwarebiotechnologypharma-companiesdigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal namePepticov Ltd.
Founded2021-1
Employees (exact)6

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516325479
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-01-20
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2023
Active charges / liens0
Registry events1 — violation (1)
Registered addressכפר ההייטק גבעת רם 2 ירושלים

Recent registry events

DateEvent
2026-06-25עדכון הפרה